Cargando…
Antiviral and bivalent vaccine efficacy against an omicron XBB.1.5 isolate
| Autores principales: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9908083/ https://www.ncbi.nlm.nih.gov/pubmed/36773622 http://dx.doi.org/10.1016/S1473-3099(23)00070-1 |
| _version_ | 1784884307894992896 |
|---|---|
| author | Uraki, Ryuta Ito, Mutsumi Kiso, Maki Yamayoshi, Seiya Iwatsuki-Horimoto, Kiyoko Furusawa, Yuri Sakai-Tagawa, Yuko Imai, Masaki Koga, Michiko Yamamoto, Shinya Adachi, Eisuke Saito, Makoto Tsutsumi, Takeya Otani, Amato Kikuchi, Tetsuhiro Yotsuyanagi, Hiroshi Halfmann, Peter J Pekosz, Andrew Kawaoka, Yoshihiro |
| author_facet | Uraki, Ryuta Ito, Mutsumi Kiso, Maki Yamayoshi, Seiya Iwatsuki-Horimoto, Kiyoko Furusawa, Yuri Sakai-Tagawa, Yuko Imai, Masaki Koga, Michiko Yamamoto, Shinya Adachi, Eisuke Saito, Makoto Tsutsumi, Takeya Otani, Amato Kikuchi, Tetsuhiro Yotsuyanagi, Hiroshi Halfmann, Peter J Pekosz, Andrew Kawaoka, Yoshihiro |
| author_sort | Uraki, Ryuta |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9908083 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-99080832023-02-09 Antiviral and bivalent vaccine efficacy against an omicron XBB.1.5 isolate Uraki, Ryuta Ito, Mutsumi Kiso, Maki Yamayoshi, Seiya Iwatsuki-Horimoto, Kiyoko Furusawa, Yuri Sakai-Tagawa, Yuko Imai, Masaki Koga, Michiko Yamamoto, Shinya Adachi, Eisuke Saito, Makoto Tsutsumi, Takeya Otani, Amato Kikuchi, Tetsuhiro Yotsuyanagi, Hiroshi Halfmann, Peter J Pekosz, Andrew Kawaoka, Yoshihiro Lancet Infect Dis Correspondence Elsevier Ltd. 2023-04 2023-02-08 /pmc/articles/PMC9908083/ /pubmed/36773622 http://dx.doi.org/10.1016/S1473-3099(23)00070-1 Text en © 2023 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Correspondence Uraki, Ryuta Ito, Mutsumi Kiso, Maki Yamayoshi, Seiya Iwatsuki-Horimoto, Kiyoko Furusawa, Yuri Sakai-Tagawa, Yuko Imai, Masaki Koga, Michiko Yamamoto, Shinya Adachi, Eisuke Saito, Makoto Tsutsumi, Takeya Otani, Amato Kikuchi, Tetsuhiro Yotsuyanagi, Hiroshi Halfmann, Peter J Pekosz, Andrew Kawaoka, Yoshihiro Antiviral and bivalent vaccine efficacy against an omicron XBB.1.5 isolate |
| title | Antiviral and bivalent vaccine efficacy against an omicron XBB.1.5 isolate |
| title_full | Antiviral and bivalent vaccine efficacy against an omicron XBB.1.5 isolate |
| title_fullStr | Antiviral and bivalent vaccine efficacy against an omicron XBB.1.5 isolate |
| title_full_unstemmed | Antiviral and bivalent vaccine efficacy against an omicron XBB.1.5 isolate |
| title_short | Antiviral and bivalent vaccine efficacy against an omicron XBB.1.5 isolate |
| title_sort | antiviral and bivalent vaccine efficacy against an omicron xbb.1.5 isolate |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9908083/ https://www.ncbi.nlm.nih.gov/pubmed/36773622 http://dx.doi.org/10.1016/S1473-3099(23)00070-1 |
| work_keys_str_mv | AT urakiryuta antiviralandbivalentvaccineefficacyagainstanomicronxbb15isolate AT itomutsumi antiviralandbivalentvaccineefficacyagainstanomicronxbb15isolate AT kisomaki antiviralandbivalentvaccineefficacyagainstanomicronxbb15isolate AT yamayoshiseiya antiviralandbivalentvaccineefficacyagainstanomicronxbb15isolate AT iwatsukihorimotokiyoko antiviralandbivalentvaccineefficacyagainstanomicronxbb15isolate AT furusawayuri antiviralandbivalentvaccineefficacyagainstanomicronxbb15isolate AT sakaitagawayuko antiviralandbivalentvaccineefficacyagainstanomicronxbb15isolate AT imaimasaki antiviralandbivalentvaccineefficacyagainstanomicronxbb15isolate AT kogamichiko antiviralandbivalentvaccineefficacyagainstanomicronxbb15isolate AT yamamotoshinya antiviralandbivalentvaccineefficacyagainstanomicronxbb15isolate AT adachieisuke antiviralandbivalentvaccineefficacyagainstanomicronxbb15isolate AT saitomakoto antiviralandbivalentvaccineefficacyagainstanomicronxbb15isolate AT tsutsumitakeya antiviralandbivalentvaccineefficacyagainstanomicronxbb15isolate AT otaniamato antiviralandbivalentvaccineefficacyagainstanomicronxbb15isolate AT kikuchitetsuhiro antiviralandbivalentvaccineefficacyagainstanomicronxbb15isolate AT yotsuyanagihiroshi antiviralandbivalentvaccineefficacyagainstanomicronxbb15isolate AT halfmannpeterj antiviralandbivalentvaccineefficacyagainstanomicronxbb15isolate AT pekoszandrew antiviralandbivalentvaccineefficacyagainstanomicronxbb15isolate AT kawaokayoshihiro antiviralandbivalentvaccineefficacyagainstanomicronxbb15isolate |